Bright Uro raised $23 million in Series A funds to help achieve FDA clearance for its urodynamics system and launch the product in the U.S. Should it be cleared, the system will become the first product on the market able perform urodynamic monitoring wirelessly and without a catheter, the company's CEO said.
Viome Life Sciences' Series C funding round included participation from Khosla Ventures, Bold Capital and WRG Ventures. In total, Viome has raised $175 million.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
While they’ve always served as hubs for medication and other basic necessities, now is the time to innovate and remove the burden from the healthcare system. It’s time for pharmacies to become central locations for all things health and wellness– diagnostics included.
Virginia-based Careviso recently raised $17 million in Series B funds. The company — which is focused on improving transparency and access for diagnostic testing — will use the funds to enhance its platform's price transparency tool and deploy it in physician offices so it can be used at the point of care.
The site will return a list of nearby labs that are in the patient’s insurance network, and the test can then be scheduled online.
In honor of National Women’s Health Week, we are highlighting startups focused on women’s health. These companies and these new devices help women stay healthy without draining their wallets. To find more about women’s health and National Women’s Health Week, check out #NWHW and #maternalhealth on Twitter, in addition to the following stories. nVision Medical […]
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.